AXGN Axogen Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: AXGN

Price (delayed)

$42.285

Market cap

$2.25B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.63

Enterprise value

$2.18B

?
Relative Growth: Rel. Growth: 33
Relative Strength: Rel. Strength: 94
Relative Valuation: Rel. Valuation: 9
Relative Profitability: Rel. Profitability: 28

Axogen (AXGN) is the leading company focused specifically on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. Axogen employees are passionate about helping to restore ...

Highlights
The equity has soared by 132% YoY and by 90% QoQ
Axogen's quick ratio has soared by 103% YoY and by 67% from the previous quarter
Axogen's net income has shrunk by 100% QoQ
The company's EPS has shrunk by 85% QoQ
Sector: Healthcare
Industry: Medical Devices
Website: http://www.axogeninc.com
Peers: MDT TMO BSX

Key stats

What are the main financial stats of AXGN

AXGN stock price

How has the Axogen stock price performed over time
Intraday
4.07%
1 week
4.61%
1 month
-0.81%
1 year
287.94%
YTD
29.19%
QTD
27.63%

Financial performance

How have Axogen's revenue and profit performed over time
Revenue
$238.11M
Gross profit
$178.61M
Operating income
-$9.02M
Net income
-$31.45M
Gross margin
75%
Net margin
-13.2%
Axogen's net income has shrunk by 100% QoQ
The company's net margin has shrunk by 89% QoQ
Axogen's gross profit has increased by 24% YoY and by 7% from the previous quarter
The revenue has grown by 22% YoY and by 6% from the previous quarter

Price vs fundamentals

How does AXGN's price correlate with its fundamentals

Growth

What is Axogen's growth rate over time

Valuation

What is Axogen stock price valuation
P/E
N/A
P/B
8.96
P/S
9.16
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
9.17
The company's EPS has shrunk by 85% QoQ
The equity has soared by 132% YoY and by 90% QoQ
AXGN's P/B is 66% above its 5-year quarterly average of 5.2 and 15% above its last 4 quarters average of 7.5
AXGN's P/S is 144% above its 5-year quarterly average of 3.6 and 76% above its last 4 quarters average of 5.0
The revenue has grown by 22% YoY and by 6% from the previous quarter

Efficiency

How efficient is Axogen business performance
The company's return on sales has shrunk by 194% QoQ
Axogen's ROE has plunged by 192% YoY and by 54% from the previous quarter
The ROA has plunged by 80% from the previous quarter

Dividends

What is AXGN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AXGN.

Financial health

How did Axogen financials performed over time
Axogen's quick ratio has soared by 103% YoY and by 67% from the previous quarter
AXGN's current ratio has surged by 66% year-on-year and by 39% since the previous quarter
The company's debt is 92% lower than its equity
The equity has soared by 132% YoY and by 90% QoQ
The debt to equity has plunged by 88% YoY and by 86% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.